HYOU1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.948200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.698240E-01
Normal-vs-Stage2
3.103200E-01
Normal-vs-Stage3
7.295200E-01
Normal-vs-Stage4
3.707000E-01
Stage1-vs-Stage2
7.974200E-01
Stage1-vs-Stage3
4.955900E-02
Stage1-vs-Stage4
9.221800E-01
Stage2-vs-Stage3
1.103830E-01
Stage2-vs-Stage4
8.929600E-01
Stage3-vs-Stage4
1.716970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.930600E-01
Normal-vs-AfricanAmerican
3.352100E-02
Normal-vs-Asian
9.991200E-01
Caucasian-vs-AfricanAmerican
9.619800E-02
Caucasian-vs-Asian
4.919600E-02
AfricanAmerican-vs-Asian
6.660900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.663800E-01
Normal-vs-Female
3.383800E-01
Male-vs-Female
2.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.729600E-01
Normal-vs-Age(41-60Yrs)
1.409410E-01
Normal-vs-Age(61-80Yrs)
3.916800E-01
Normal-vs-Age(81-100Yrs)
4.527400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.183600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.271200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.127600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.462100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.969420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.355200E-01
Normal-vs-Daily Drinker
4.055400E-01
Normal-vs-Weekly Drinker
5.773600E-01
Normal-vs-Occasional Drinker
2.348000E-01
Normal-vs-Social Drinker
1.876040E-01
Non Drinker-vs-Daily Drinker
5.947600E-01
Non Drinker-vs-Weekly Drinker
9.369200E-01
Non Drinker-vs-Occasional Drinker
7.000400E-02
Non Drinker-vs-Social Drinker
2.837600E-01
Daily Drinker-vs-Weekly Drinker
6.076200E-01
Daily Drinker-vs-Occasional Drinker
2.044400E-01
Daily Drinker-vs-Social Drinker
5.933000E-01
Weekly Drinker-vs-Occasional Drinker
1.340610E-01
Weekly Drinker-vs-Social Drinker
2.990600E-01
Occasional Drinker-vs-Social Drinker
4.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.255000E-01
Normal-vs-Grade 2
1.653560E-01
Normal-vs-Grade 3
6.506400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.441800E-01
Grade 1-vs-Grade 3
9.507200E-01
Grade 1-vs-Grade 4
2.255000E-01
Grade 2-vs-Grade 3
3.565200E-01
Grade 2-vs-Grade 4
1.653560E-01
Grade 3-vs-Grade 4
6.506400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.915800E-01
Normal-vs-NonDiabetic
2.880200E-01
Diabetic-vs-NonDiabetic
2.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.693400E-01
Normal-vs-NoPancreatitis
3.190000E-01
Pancreatitis-vs-NoPancreatitis
8.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.350200E-01
Normal-vs-N1
3.142400E-01
N0-vs-N1
9.095200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.442810E-01
Normal-vs-TP53-NonMutant
2.935000E-01
TP53-Mutant-vs-TP53-NonMutant
1.675360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
